GitLife Biotech
PrivateLast Round
Seed
Jun 1, 2026
Total Funding Raised
$1.27M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GitLife Biotech operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne. Its latest recorded funding round was a Grant round in October 2025.
GitLife Biotech is a synthetic biology company that provides a bio-digital platform with version control and DNA-based biosecurity tools to improve traceability and intellectual property protection for engineered biological assets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Data Protection, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GitLife Biotech Comparables
Compare GitLife Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TeselaGen Biotechnology | 69% | |
| Siemens | 61% | |
| SciNote LLC | 60% |
For institutional investors. Book with your work email.
GitLife Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2026 | ||||
| Grant | Oct 8, 2025 | ||||
| Grant | Feb 1, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Pre Seed | Aug 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GitLife Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Innovate UK | Grant |
| Cambridge Future Tech | Pre Seed |
| Mandashi | Pre Seed |
| SFC Capital | Pre Seed |
| Newcastle University | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 1763% MoM, from 59 to 1.1K.
- Jun 1, 2026
$2.56M raised in Seed round.
For institutional investors. Book with your work email.
GitLife Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GitLife Biotech's valuation, stock price, and market status.
Is GitLife Biotech a public or private company?
GitLife Biotech is a private company.
What is the current stock price of GitLife Biotech?
GitLife Biotech is a private company, so its shares have no public market price. Caplight tracks GitLife Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GitLife Biotech worth (valuation)?
Valuation information for GitLife Biotech is not publicly available.
Can I buy GitLife Biotech stock?
GitLife Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GitLife Biotech's last funding round?
GitLife Biotech's most recent funding round was Seed on June 1, 2026.
Who are the main investors in GitLife Biotech?
Key investors in GitLife Biotech include Innovate UK.
Will GitLife Biotech IPO soon?
No public IPO plans have been announced for GitLife Biotech.
How can I track GitLife Biotech secondary market activity?
Caplight tracks bids, offers, and trades in GitLife Biotech's shares on secondary markets.